Learn more about DiMe work
that Takeda is involved in
We are very grateful for Takeda’s thought leadership and contribution toward these critically important efforts.
See how your colleagues are using DiMe resources
“The goal of this [validation study, the final step in V3] was to determine if this portable [and] understand the clinical validation in the specific narcolepsy population. With the goal of saying, if this is fit-for-purpose, how can we use this in our future clinical trials?” – Ariel Dowling, Head of Sensing and Measurement, Takeda
Learn more about this V3 in Action story:
“Validation of a novel device intended for remote clinical monitoring is essential to determine if the device is fit-for-purpose for the specific patient population.”
— Ariel Dowling, Director of Digital Strategy, Takeda
“The Playbook provided a useful reference and a single place where we could find the answers to many questions as well as credibility to our work.”
